“We are pleased with the successful completion of the inspection at our Vizag facility. This accomplishment is a testament to our commitment to upholding global quality standards across all our manufacturing sites, and to provide quality affordable healthcare for all,” said Nilesh Gupta, managing director of Lupin.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AHQLlck
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Lupin's Vizag unit gets no observations from USFDA
0 comments:
Post a Comment